C9279 D Injection, ibuprofen, 100 mg
C9286 D Injection, belatacept, 1 mg
C9287 D Injection, brentuximab vedotin, 1 mg
C9288 D Injection, centruroides (scorpion) immune f(ab)2 (equine), 1 vial
C9289 D Injection, asparaginase erwinia chrysanthemi, 1,000 international units (i. U. )
C9291 D Injection, aflibercept, 2 mg vial
C9366 D Epifix, per square centimeter
C9368 D Grafix core, per square centimeter
C9369 D Grafix prime, per square centimeter
C9732 D Insertion of ocular telescope prosthesis including removal of crystalline lens
D0360 D Cone beam ct - craniofacial data capture
D0362 D Cone beam - two-dimensional image reconstruction using existing data, includes
D1203 D Topical application of fluoride - child
D1204 D Topical application of fluoride - adult
D4271 D Free soft tissue graft procedure (including donor site surgery)
D6254 D Interim pontic
D6795 D Interim retainer crown
D6970 D Post and core in addition to fixed partial denture retainer, indirectly
D6972 D Prefabricated post and core in addition to bridge retainer
D6973 D Core build up for retainer, including any pins
D6976 D Each additional indirectly fabricated post - same tooth
D6977 D Each additional prefabricated post - same tooth
G0290 D Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous,
G0291 D Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous,
G0911 D Assessed level of activity and symptoms
G0912 D Level of activity and symptoms not assessed
G8447 D Patient encounter was documented using an ehr system that has been certified by
G8448 D Patient encounter was documented using a pqri qualified ehr or other acceptable
G8468 D Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker
G8469 D Clinician documented that patient with a left ventricular ejection fraction
G8470 D Patient with left ventricular ejection fraction (lvef) >=40% or documentation
G8471 D Left ventricular ejection fraction (lvef) was not performed or documented
G8472 D Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker
G8524 D Patch closure used for patient undergoing conventional cea
G8525 D Clinician documented that patient did not receive conventional cea
G8526 D Patch closure not used for patient undergoing conventional cea, reason not
G8546 D I intend to report the community-acquired pneumonia (cap) measures group
G8550 D All quality actions for the applicable measures in the community-acquired
G8675 D Most recent systolic blood pressure >= 140 mm hg
G8676 D Most recent diastolic blood pressure >= 90 mm hg
G8677 D Most recent systolic blood pressure < 130 mm hg
G8678 D Most recent systolic blood pressure 130 to 139 mm hg
G8679 D Most recent diastolic blood pressure < 80 mm hg
G8680 D Most recent diastolic blood pressure 80 - 89 mm hg
G8695 D Left ventricular ejection fraction (lvef) >= 40% or documentation as mildly
G8715 D Hemodialysis treatment performed less than three times per week or greater than
G8716 D Documentation of reason(s) for patient not having greater than or equal to 1. 2
G8727 D Patient receiving hemodialysis, peritoneal dialysis or kidney transplantation
G8750 D Presence of signs of melanoma (cough, dyspnea, tenderness, localized neurologic
G8760 D All quality actions for the applicable measures in the epilepsy measures group
G8786 D Severity of angina assessed according to level of activity
G8787 D Angina assessed as present
G8788 D Angina assessed as absent
G8789 D Severity of angina not assessed according to level of activity
G8802 D Pregnancy test (urine or serum) ordered
G8803 D Pregnancy test (urine or serum) not ordered for reasons documented by clinician
G8805 D Pregnancy test (urine or serum) was not ordered, reason not specified
G8819 D Aneurysm minor diameter <= 5. 5 cm
G8820 D Aneurysm minor diameter 5. 6-6. 0 cm
G8821 D Abdominal aortic aneurysm is not infarenal
G8822 D Male patients with aneurysms minor diameter >6 cm
G8823 D Female patients with aneurysm minor diameter >6cm
G8824 D Female patients with aneurysm minor diameter 5. 6-6. 0 cm
G8828 D Aneurysm minor diameter <= 5. 5 cm for men
G8829 D Aneurysm minor diameter 5. 6-6. 0 cm for men
G8830 D Aneurysm minor diameter >6cm for men
G8831 D Aneurysm minor diameter >6cm for women
G8832 D Aneurysm minor diameter 5. 6-6. 0 cm for women
G8836 D Symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea
G8837 D Other symptomatic patient with ipsilateral carotid territory tia or stroke >
G8847 D Positive airway pressure therapy not prescribed
G8901 D I intend to report the epilepsy measures group
G9141 D Influenza a (h1n1) immunization administration (includes the physician
G9142 D Influenza a (h1n1) vaccine, any route of administration
J1051 D Injection, medroxyprogesterone acetate, 50 mg
J1055 D Injection, medroxyprogesterone acetate for contraceptive use, 150 mg
J1056 D Injection, medroxyprogesterone acetate / estradiol cypionate, 5mg / 25mg
J1680 D Injection, human fibrinogen concentrate, 100 mg
J8561 D Everolimus, oral, 0. 25 mg
J9001 D Injection, doxorubicin hydrochloride, all lipid formulations, 10 mg
K0741 D Portable gaseous oxygen system, rental, includes portable container, regulator,
K0742 D Portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster
Q2045 D Injection, human fibrinogen concentrate, 1 mg
Q2046 D Injection, aflibercept, 1 mg
Q2047 D Injection, peginesatide, 0. 1 mg (for esrd on dialysis)
Q2048 D Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
S3711 D Circulating tumor cell test
S3713 D Kras mutation analysis testing
S3818 D Complete gene sequence analysis; brca1 gene
S3819 D Complete gene sequence analysis; brca2 gene
S3820 D Complete brca1 and brca2 gene sequence analysis for susceptibility to breast
S3822 D Single mutation analysis (in individual with a known brca1 or brca2 mutation in
S3823 D Three-mutation brca1 and brca2 analysis for susceptibility to breast and
S3828 D Complete gene sequence analysis; mlh1 gene
S3829 D Complete gene sequence analysis; msh2 gene
S3830 D Complete mlh1 and msh2 gene sequence analysis for hereditary nonpolyposis
S3831 D Single-mutation analysis (in individual with a known mlh1 and msh2 mutation in
S3835 D Complete gene sequence analysis for cystic fibrosis genetic testing
S3837 D Complete gene sequence analysis for hemochromatosis genetic testing
S3843 D Dna analysis of the f5 gene for susceptibility to factor v leiden thrombophilia
S3847 D Genetic testing for tay-sachs disease
S3848 D Genetic testing for gaucher disease
S3851 D Genetic testing for canavan disease
S3860 D Genetic testing, comprehensive cardiac ion channel analysis, for variants in 5
S3862 D Genetic testing, family-specific ion channel analysis, for blood-relatives of
S8049 D Intraoperative radiation therapy (single administration)
S9109 D Congestive heart failure telemonitoring, equipment rental, including telescale,
29590 D Denis-browne splint strapping
31656 D Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when
31715 D Transtracheal injection for bronchography
32420 D Pneumocentesis, puncture of lung for aspiration
32421 D Thoracentesis, puncture of pleural cavity for aspiration, initial or subsequent
32422 D Thoracentesis with insertion of tube, includes water seal (eg, for
37201 D Transcatheter therapy, infusion for thrombolysis other than coronary
37203 D Transcatheter retrieval, percutaneous, of intravascular foreign body (eg,
37209 D Exchange of a previously placed intravascular catheter during thrombolytic
43234 D Upper gastrointestinal endoscopy, simple primary examination (eg, with small
65805 D Paracentesis of anterior chamber of eye (separate procedure); with therapeutic
71040 D Bronchography, unilateral, radiological supervision and interpretation
71060 D Bronchography, bilateral, radiological supervision and interpretation
75650 D Angiography, cervicocerebral, catheter, including vessel origin, radiological
75660 D Angiography, external carotid, unilateral, selective, radiological supervision
75662 D Angiography, external carotid, bilateral, selective, radiological supervision
75665 D Angiography, carotid, cerebral, unilateral, radiological supervision and
75671 D Angiography, carotid, cerebral, bilateral, radiological supervision and
75676 D Angiography, carotid, cervical, unilateral, radiological supervision and
75680 D Angiography, carotid, cervical, bilateral, radiological supervision and
75685 D Angiography, vertebral, cervical, and/or intracranial, radiological supervision
75900 D Exchange of a previously placed intravascular catheter during thrombolytic
75961 D Transcatheter retrieval, percutaneous, of intravascular foreign body (eg,
78000 D Thyroid uptake; single determination
78001 D Thyroid uptake; multiple determinations
78003 D Thyroid uptake; stimulation, suppression or discharge (not including initial
78006 D Thyroid imaging, with uptake; single determination
78007 D Thyroid imaging, with uptake; multiple determinations
78010 D Thyroid imaging; only
78011 D Thyroid imaging; with vascular flow
83890 D Molecular diagnostics; molecular isolation or extraction, each nucleic acid
83891 D Molecular diagnostics; isolation or extraction of highly purified nucleic acid,
83892 D Molecular diagnostics; enzymatic digestion, each enzyme treatment
83893 D Molecular diagnostics; dot/slot blot production, each nucleic acid preparation
83894 D Molecular diagnostics; separation by gel electrophoresis (eg, agarose,
83896 D Molecular diagnostics; nucleic acid probe, each
83897 D Molecular diagnostics; nucleic acid transfer (eg, southern, northern), each
83898 D Molecular diagnostics; amplification, target, each nucleic acid sequence
83900 D Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid
83901 D Molecular diagnostics; amplification, target, multiplex, each additional
83902 D Molecular diagnostics; reverse transcription
83903 D Molecular diagnostics; mutation scanning, by physical properties (eg, single
83904 D Molecular diagnostics; mutation identification by sequencing, single segment,
83905 D Molecular diagnostics; mutation identification by allele specific
83906 D Molecular diagnostics; mutation identification by allele specific translation,
83907 D Molecular diagnostics; lysis of cells prior to nucleic acid extraction (eg,
83908 D Molecular diagnostics; amplification, signal, each nucleic acid sequence
83909 D Molecular diagnostics; separation and identification by high resolution
83912 D Molecular diagnostics; interpretation and report
83913 D Molecular diagnostics; rna stabilization
83914 D Mutation identification by enzymatic ligation or primer extension, single
88384 D Array-based evaluation of multiple molecular probes; 11 through 50 probes
88385 D Array-based evaluation of multiple molecular probes; 51 through 250 probes
88386 D Array-based evaluation of multiple molecular probes; 251 through 500 probes
90665 D Lyme disease vaccine, adult dosage, for intramuscular use
90701 D Diphtheria, tetanus toxoids, and whole cell pertussis vaccine (dtp), for
90718 D Tetanus and diphtheria toxoids (td) adsorbed when administered to individuals 7
90801 D Psychiatric diagnostic interview examination
90802 D Interactive psychiatric diagnostic interview examination using play equipment,
90804 D Individual psychotherapy, insight oriented, behavior modifying and/or
90805 D Individual psychotherapy, insight oriented, behavior modifying and/or
90806 D Individual psychotherapy, insight oriented, behavior modifying and/or
90807 D Individual psychotherapy, insight oriented, behavior modifying and/or
90808 D Individual psychotherapy, insight oriented, behavior modifying and/or
90809 D Individual psychotherapy, insight oriented, behavior modifying and/or
90810 D Individual psychotherapy, interactive, using play equipment, physical devices,
90811 D Individual psychotherapy, interactive, using play equipment, physical devices,
90812 D Individual psychotherapy, interactive, using play equipment, physical devices,
90813 D Individual psychotherapy, interactive, using play equipment, physical devices,
90814 D Individual psychotherapy, interactive, using play equipment, physical devices,
90815 D Individual psychotherapy, interactive, using play equipment, physical devices,
90816 D Individual psychotherapy, insight oriented, behavior modifying and/or
90817 D Individual psychotherapy, insight oriented, behavior modifying and/or
90818 D Individual psychotherapy, insight oriented, behavior modifying and/or
90819 D Individual psychotherapy, insight oriented, behavior modifying and/or
90821 D Individual psychotherapy, insight oriented, behavior modifying and/or
90822 D Individual psychotherapy, insight oriented, behavior modifying and/or
90823 D Individual psychotherapy, interactive, using play equipment, physical devices,
90824 D Individual psychotherapy, interactive, using play equipment, physical devices,
90826 D Individual psychotherapy, interactive, using play equipment, physical devices,
90827 D Individual psychotherapy, interactive, using play equipment, physical devices,
90828 D Individual psychotherapy, interactive, using play equipment, physical devices,
90829 D Individual psychotherapy, interactive, using play equipment, physical devices,
90857 D Interactive group psychotherapy
90862 D Pharmacologic management, including prescription, use, and review of medication
92980 D Transcatheter placement of an intracoronary stent(s), percutaneous, with or
92981 D Transcatheter placement of an intracoronary stent(s), percutaneous, with or
92982 D Percutaneous transluminal coronary balloon angioplasty; single vessel
92984 D Percutaneous transluminal coronary balloon angioplasty; each additional vessel
92995 D Percutaneous transluminal coronary atherectomy, by mechanical or other method,
92996 D Percutaneous transluminal coronary atherectomy, by mechanical or other method,
93651 D Intracardiac catheter ablation of arrhythmogenic focus; for treatment of
93652 D Intracardiac catheter ablation of arrhythmogenic focus; for treatment of
95010 D Percutaneous tests (scratch, puncture, prick) sequential and incremental, with
95015 D Intracutaneous (intradermal) tests, sequential and incremental, with drugs,
95075 D Ingestion challenge test (sequential and incremental ingestion of test items,
95900 D Nerve conduction, amplitude and latency/velocity study, each nerve; motor,
95903 D Nerve conduction, amplitude and latency/velocity study, each nerve; motor, with
95904 D Nerve conduction, amplitude and latency/velocity study, each nerve; sensory
95920 D Intraoperative neurophysiology testing, per hour (list separately in addition
95934 D H-reflex, amplitude and latency study; record gastrocnemius/soleus muscle
95936 D H-reflex, amplitude and latency study; record muscle other than
0030T D Antiprothrombin (phospholipid cofactor) antibody, each ig class
0048T D Implantation of a ventricular assist device, extracorporeal, percutaneous
0050T D Removal of a ventricular assist device, extracorporeal, percutaneous
0173T D Monitoring of intraocular pressure during vitrectomy surgery (list separately
0242T D Gastrointestinal tract transit and pressure measurement, stomach through colon,
0250T D Airway sizing and insertion of bronchial valve(s), each lobe (list separately
0251T D Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when
0252T D Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when
0256T D Implantation of catheter-delivered prosthetic aortic heart valve; endovascular
0257T D Implantation of catheter-delivered prosthetic aortic heart valve; open thoracic
0258T D Transthoracic cardiac exposure (eg, sternotomy, thoracotomy, subxiphoid) for
0259T D Transthoracic cardiac exposure (eg, sternotomy, thoracotomy, subxiphoid) for
0276T D Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when
0277T D Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when
0279T D Cell enumeration using immunologic selection and identification in fluid
0280T D Cell enumeration using immunologic selection and identification in fluid
C9286 D Injection, belatacept, 1 mg
C9287 D Injection, brentuximab vedotin, 1 mg
C9288 D Injection, centruroides (scorpion) immune f(ab)2 (equine), 1 vial
C9289 D Injection, asparaginase erwinia chrysanthemi, 1,000 international units (i. U. )
C9291 D Injection, aflibercept, 2 mg vial
C9366 D Epifix, per square centimeter
C9368 D Grafix core, per square centimeter
C9369 D Grafix prime, per square centimeter
C9732 D Insertion of ocular telescope prosthesis including removal of crystalline lens
D0360 D Cone beam ct - craniofacial data capture
D0362 D Cone beam - two-dimensional image reconstruction using existing data, includes
D1203 D Topical application of fluoride - child
D1204 D Topical application of fluoride - adult
D4271 D Free soft tissue graft procedure (including donor site surgery)
D6254 D Interim pontic
D6795 D Interim retainer crown
D6970 D Post and core in addition to fixed partial denture retainer, indirectly
D6972 D Prefabricated post and core in addition to bridge retainer
D6973 D Core build up for retainer, including any pins
D6976 D Each additional indirectly fabricated post - same tooth
D6977 D Each additional prefabricated post - same tooth
G0290 D Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous,
G0291 D Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous,
G0911 D Assessed level of activity and symptoms
G0912 D Level of activity and symptoms not assessed
G8447 D Patient encounter was documented using an ehr system that has been certified by
G8448 D Patient encounter was documented using a pqri qualified ehr or other acceptable
G8468 D Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker
G8469 D Clinician documented that patient with a left ventricular ejection fraction
G8470 D Patient with left ventricular ejection fraction (lvef) >=40% or documentation
G8471 D Left ventricular ejection fraction (lvef) was not performed or documented
G8472 D Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker
G8524 D Patch closure used for patient undergoing conventional cea
G8525 D Clinician documented that patient did not receive conventional cea
G8526 D Patch closure not used for patient undergoing conventional cea, reason not
G8546 D I intend to report the community-acquired pneumonia (cap) measures group
G8550 D All quality actions for the applicable measures in the community-acquired
G8675 D Most recent systolic blood pressure >= 140 mm hg
G8676 D Most recent diastolic blood pressure >= 90 mm hg
G8677 D Most recent systolic blood pressure < 130 mm hg
G8678 D Most recent systolic blood pressure 130 to 139 mm hg
G8679 D Most recent diastolic blood pressure < 80 mm hg
G8680 D Most recent diastolic blood pressure 80 - 89 mm hg
G8695 D Left ventricular ejection fraction (lvef) >= 40% or documentation as mildly
G8715 D Hemodialysis treatment performed less than three times per week or greater than
G8716 D Documentation of reason(s) for patient not having greater than or equal to 1. 2
G8727 D Patient receiving hemodialysis, peritoneal dialysis or kidney transplantation
G8750 D Presence of signs of melanoma (cough, dyspnea, tenderness, localized neurologic
G8760 D All quality actions for the applicable measures in the epilepsy measures group
G8786 D Severity of angina assessed according to level of activity
G8787 D Angina assessed as present
G8788 D Angina assessed as absent
G8789 D Severity of angina not assessed according to level of activity
G8802 D Pregnancy test (urine or serum) ordered
G8803 D Pregnancy test (urine or serum) not ordered for reasons documented by clinician
G8805 D Pregnancy test (urine or serum) was not ordered, reason not specified
G8819 D Aneurysm minor diameter <= 5. 5 cm
G8820 D Aneurysm minor diameter 5. 6-6. 0 cm
G8821 D Abdominal aortic aneurysm is not infarenal
G8822 D Male patients with aneurysms minor diameter >6 cm
G8823 D Female patients with aneurysm minor diameter >6cm
G8824 D Female patients with aneurysm minor diameter 5. 6-6. 0 cm
G8828 D Aneurysm minor diameter <= 5. 5 cm for men
G8829 D Aneurysm minor diameter 5. 6-6. 0 cm for men
G8830 D Aneurysm minor diameter >6cm for men
G8831 D Aneurysm minor diameter >6cm for women
G8832 D Aneurysm minor diameter 5. 6-6. 0 cm for women
G8836 D Symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea
G8837 D Other symptomatic patient with ipsilateral carotid territory tia or stroke >
G8847 D Positive airway pressure therapy not prescribed
G8901 D I intend to report the epilepsy measures group
G9141 D Influenza a (h1n1) immunization administration (includes the physician
G9142 D Influenza a (h1n1) vaccine, any route of administration
J1051 D Injection, medroxyprogesterone acetate, 50 mg
J1055 D Injection, medroxyprogesterone acetate for contraceptive use, 150 mg
J1056 D Injection, medroxyprogesterone acetate / estradiol cypionate, 5mg / 25mg
J1680 D Injection, human fibrinogen concentrate, 100 mg
J8561 D Everolimus, oral, 0. 25 mg
J9001 D Injection, doxorubicin hydrochloride, all lipid formulations, 10 mg
K0741 D Portable gaseous oxygen system, rental, includes portable container, regulator,
K0742 D Portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster
Q2045 D Injection, human fibrinogen concentrate, 1 mg
Q2046 D Injection, aflibercept, 1 mg
Q2047 D Injection, peginesatide, 0. 1 mg (for esrd on dialysis)
Q2048 D Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
S3711 D Circulating tumor cell test
S3713 D Kras mutation analysis testing
S3818 D Complete gene sequence analysis; brca1 gene
S3819 D Complete gene sequence analysis; brca2 gene
S3820 D Complete brca1 and brca2 gene sequence analysis for susceptibility to breast
S3822 D Single mutation analysis (in individual with a known brca1 or brca2 mutation in
S3823 D Three-mutation brca1 and brca2 analysis for susceptibility to breast and
S3828 D Complete gene sequence analysis; mlh1 gene
S3829 D Complete gene sequence analysis; msh2 gene
S3830 D Complete mlh1 and msh2 gene sequence analysis for hereditary nonpolyposis
S3831 D Single-mutation analysis (in individual with a known mlh1 and msh2 mutation in
S3835 D Complete gene sequence analysis for cystic fibrosis genetic testing
S3837 D Complete gene sequence analysis for hemochromatosis genetic testing
S3843 D Dna analysis of the f5 gene for susceptibility to factor v leiden thrombophilia
S3847 D Genetic testing for tay-sachs disease
S3848 D Genetic testing for gaucher disease
S3851 D Genetic testing for canavan disease
S3860 D Genetic testing, comprehensive cardiac ion channel analysis, for variants in 5
S3862 D Genetic testing, family-specific ion channel analysis, for blood-relatives of
S8049 D Intraoperative radiation therapy (single administration)
S9109 D Congestive heart failure telemonitoring, equipment rental, including telescale,
29590 D Denis-browne splint strapping
31656 D Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when
31715 D Transtracheal injection for bronchography
32420 D Pneumocentesis, puncture of lung for aspiration
32421 D Thoracentesis, puncture of pleural cavity for aspiration, initial or subsequent
32422 D Thoracentesis with insertion of tube, includes water seal (eg, for
37201 D Transcatheter therapy, infusion for thrombolysis other than coronary
37203 D Transcatheter retrieval, percutaneous, of intravascular foreign body (eg,
37209 D Exchange of a previously placed intravascular catheter during thrombolytic
43234 D Upper gastrointestinal endoscopy, simple primary examination (eg, with small
65805 D Paracentesis of anterior chamber of eye (separate procedure); with therapeutic
71040 D Bronchography, unilateral, radiological supervision and interpretation
71060 D Bronchography, bilateral, radiological supervision and interpretation
75650 D Angiography, cervicocerebral, catheter, including vessel origin, radiological
75660 D Angiography, external carotid, unilateral, selective, radiological supervision
75662 D Angiography, external carotid, bilateral, selective, radiological supervision
75665 D Angiography, carotid, cerebral, unilateral, radiological supervision and
75671 D Angiography, carotid, cerebral, bilateral, radiological supervision and
75676 D Angiography, carotid, cervical, unilateral, radiological supervision and
75680 D Angiography, carotid, cervical, bilateral, radiological supervision and
75685 D Angiography, vertebral, cervical, and/or intracranial, radiological supervision
75900 D Exchange of a previously placed intravascular catheter during thrombolytic
75961 D Transcatheter retrieval, percutaneous, of intravascular foreign body (eg,
78000 D Thyroid uptake; single determination
78001 D Thyroid uptake; multiple determinations
78003 D Thyroid uptake; stimulation, suppression or discharge (not including initial
78006 D Thyroid imaging, with uptake; single determination
78007 D Thyroid imaging, with uptake; multiple determinations
78010 D Thyroid imaging; only
78011 D Thyroid imaging; with vascular flow
83890 D Molecular diagnostics; molecular isolation or extraction, each nucleic acid
83891 D Molecular diagnostics; isolation or extraction of highly purified nucleic acid,
83892 D Molecular diagnostics; enzymatic digestion, each enzyme treatment
83893 D Molecular diagnostics; dot/slot blot production, each nucleic acid preparation
83894 D Molecular diagnostics; separation by gel electrophoresis (eg, agarose,
83896 D Molecular diagnostics; nucleic acid probe, each
83897 D Molecular diagnostics; nucleic acid transfer (eg, southern, northern), each
83898 D Molecular diagnostics; amplification, target, each nucleic acid sequence
83900 D Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid
83901 D Molecular diagnostics; amplification, target, multiplex, each additional
83902 D Molecular diagnostics; reverse transcription
83903 D Molecular diagnostics; mutation scanning, by physical properties (eg, single
83904 D Molecular diagnostics; mutation identification by sequencing, single segment,
83905 D Molecular diagnostics; mutation identification by allele specific
83906 D Molecular diagnostics; mutation identification by allele specific translation,
83907 D Molecular diagnostics; lysis of cells prior to nucleic acid extraction (eg,
83908 D Molecular diagnostics; amplification, signal, each nucleic acid sequence
83909 D Molecular diagnostics; separation and identification by high resolution
83912 D Molecular diagnostics; interpretation and report
83913 D Molecular diagnostics; rna stabilization
83914 D Mutation identification by enzymatic ligation or primer extension, single
88384 D Array-based evaluation of multiple molecular probes; 11 through 50 probes
88385 D Array-based evaluation of multiple molecular probes; 51 through 250 probes
88386 D Array-based evaluation of multiple molecular probes; 251 through 500 probes
90665 D Lyme disease vaccine, adult dosage, for intramuscular use
90701 D Diphtheria, tetanus toxoids, and whole cell pertussis vaccine (dtp), for
90718 D Tetanus and diphtheria toxoids (td) adsorbed when administered to individuals 7
90801 D Psychiatric diagnostic interview examination
90802 D Interactive psychiatric diagnostic interview examination using play equipment,
90804 D Individual psychotherapy, insight oriented, behavior modifying and/or
90805 D Individual psychotherapy, insight oriented, behavior modifying and/or
90806 D Individual psychotherapy, insight oriented, behavior modifying and/or
90807 D Individual psychotherapy, insight oriented, behavior modifying and/or
90808 D Individual psychotherapy, insight oriented, behavior modifying and/or
90809 D Individual psychotherapy, insight oriented, behavior modifying and/or
90810 D Individual psychotherapy, interactive, using play equipment, physical devices,
90811 D Individual psychotherapy, interactive, using play equipment, physical devices,
90812 D Individual psychotherapy, interactive, using play equipment, physical devices,
90813 D Individual psychotherapy, interactive, using play equipment, physical devices,
90814 D Individual psychotherapy, interactive, using play equipment, physical devices,
90815 D Individual psychotherapy, interactive, using play equipment, physical devices,
90816 D Individual psychotherapy, insight oriented, behavior modifying and/or
90817 D Individual psychotherapy, insight oriented, behavior modifying and/or
90818 D Individual psychotherapy, insight oriented, behavior modifying and/or
90819 D Individual psychotherapy, insight oriented, behavior modifying and/or
90821 D Individual psychotherapy, insight oriented, behavior modifying and/or
90822 D Individual psychotherapy, insight oriented, behavior modifying and/or
90823 D Individual psychotherapy, interactive, using play equipment, physical devices,
90824 D Individual psychotherapy, interactive, using play equipment, physical devices,
90826 D Individual psychotherapy, interactive, using play equipment, physical devices,
90827 D Individual psychotherapy, interactive, using play equipment, physical devices,
90828 D Individual psychotherapy, interactive, using play equipment, physical devices,
90829 D Individual psychotherapy, interactive, using play equipment, physical devices,
90857 D Interactive group psychotherapy
90862 D Pharmacologic management, including prescription, use, and review of medication
92980 D Transcatheter placement of an intracoronary stent(s), percutaneous, with or
92981 D Transcatheter placement of an intracoronary stent(s), percutaneous, with or
92982 D Percutaneous transluminal coronary balloon angioplasty; single vessel
92984 D Percutaneous transluminal coronary balloon angioplasty; each additional vessel
92995 D Percutaneous transluminal coronary atherectomy, by mechanical or other method,
92996 D Percutaneous transluminal coronary atherectomy, by mechanical or other method,
93651 D Intracardiac catheter ablation of arrhythmogenic focus; for treatment of
93652 D Intracardiac catheter ablation of arrhythmogenic focus; for treatment of
95010 D Percutaneous tests (scratch, puncture, prick) sequential and incremental, with
95015 D Intracutaneous (intradermal) tests, sequential and incremental, with drugs,
95075 D Ingestion challenge test (sequential and incremental ingestion of test items,
95900 D Nerve conduction, amplitude and latency/velocity study, each nerve; motor,
95903 D Nerve conduction, amplitude and latency/velocity study, each nerve; motor, with
95904 D Nerve conduction, amplitude and latency/velocity study, each nerve; sensory
95920 D Intraoperative neurophysiology testing, per hour (list separately in addition
95934 D H-reflex, amplitude and latency study; record gastrocnemius/soleus muscle
95936 D H-reflex, amplitude and latency study; record muscle other than
0030T D Antiprothrombin (phospholipid cofactor) antibody, each ig class
0048T D Implantation of a ventricular assist device, extracorporeal, percutaneous
0050T D Removal of a ventricular assist device, extracorporeal, percutaneous
0173T D Monitoring of intraocular pressure during vitrectomy surgery (list separately
0242T D Gastrointestinal tract transit and pressure measurement, stomach through colon,
0250T D Airway sizing and insertion of bronchial valve(s), each lobe (list separately
0251T D Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when
0252T D Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when
0256T D Implantation of catheter-delivered prosthetic aortic heart valve; endovascular
0257T D Implantation of catheter-delivered prosthetic aortic heart valve; open thoracic
0258T D Transthoracic cardiac exposure (eg, sternotomy, thoracotomy, subxiphoid) for
0259T D Transthoracic cardiac exposure (eg, sternotomy, thoracotomy, subxiphoid) for
0276T D Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when
0277T D Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when
0279T D Cell enumeration using immunologic selection and identification in fluid
0280T D Cell enumeration using immunologic selection and identification in fluid
Comments
Post a Comment